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Case Report

A Case of Aelurostrongylus abstrusus Infection in a Cat in ‹stanbul,
Turkey and its Treatment with Moxidectin and Levamisole
Erkut TÜZER, Müfit TOPARLAK, Ayflen GARGILI, Vedat KELEfi, Meltem ULUTAfi ESATG‹L
University of Istanbul, Veterinary Faculty, Department of Parasitology, Avc›lar, 34850 ‹stanbul - TURKEY

Received: 13.09.2000

Abstract: Larvae of Aelurostrongylus abstrusus were identified in the feces of a 2-year-old female cat suffering from dyspnea and
incoordination for 18 months. The larvae had a terminal S-shaped projection and a subterminal dorsal spine. The larvae measured
363-378x15 µm (aver. 370x15 µm). Firstly, moxidectin (0.4 mg/kg) was given subcutaneously to 3 healthy stray cats over 1 year
old to check adverse effects on cats. No adverse reaction was observed. Then a subcutaneous injection of moxidectin (0.4 mg/kg)
was given to the infected cat for treatment on day 0 and this was repeated on day 51. Seventy-nine days after the 2nd application
of moxidectin (on day 130), levamisole (8 mg/kg) was given orally to the cat. The treatment of moxidectin resulted in only a decrease
in larval output, whereas levamisole ceased it within 5 days. The clinical signs of the cat improved within 5 weeks of the first
application of moxidectin. Neither moxidectin nor levamisole caused adverse effects. This is the first case report on Aelurostrongylus
abstrusus infection in a cat in Turkey.
Key Words: Aelurostrongylus abstrusus, Cat, Moxidectin, Levamisole, Treatment, ‹stanbul, Turkey

‹stanbul’da Bir Kedide Aelurostrongylus abstrusus Enfeksiyonu ve Onun Moxidectin ve
Levamisole ile Tedavisi
Özet: Onsekiz ayd›r dispne ve inkoordinasyon flikayetleri olan iki yafl›nda difli bir kedinin d›flk›s›nda Aelurostrongylus abstrusus
larvalar› tesbit edildi. Larvalar›n arka ucunda S fleklinde bir ç›k›nt› ile subterminal dorsal bir diken mevcuttu. Larvalar›n büyüklü¤ü
363-378x15 µm (ortalama 370x15 µm) olarak ölçüldü. Önce bir yafl›ndan büyük, sa¤l›kl› 3 sokak kedisine deri alt› yolla moxidectin
(0.4 mg/kg) verilerek ilac›n kedilerde istenmeyen etkisi olup olmad›¤› kontrol edildi. Kötü reaksiyon görülmemesi üzerine, moxidectin
(0.4 mg/kg) enfekte kediye uyguland› (S›f›r›nc› gün). Ellibirinci gün moxidectin uygulamas›n›n tekrar› yap›ld›. ‹kinci moxidectin
uygulamas›ndan 79 gün sonra (130. gün) kediye oral yolla levamisole (8 mg/kg) verildi. Moxidectin tedavisi sadece larva ç›k›fl›n›
azaltt›. Fakat levamisole 5 gün içinde larva ç›k›fl›n› tamamen kesti. Kedinin klinik bulgular› ilk moxidectin uygulamas›ndan 5 hafta
sonra düzeldi. Ne moxidectin ne levamisole istenmeyen reaksiyonlara yol açmad›. Bu yay›n, Türkiye’den kedilerde Aelurostrongylus
abstrusus enfeksiyonunu tan›mlayan ilk rapordur.
Anahtar Sözcükler: Aelurostrongylus abstrusus, Kedi, Moxidectin, Levamisole, Tedavi, ‹stanbul, Türkiye

Introduction

Aelurostrongylus abstrusus localizes in the lungs of
cats and occurs in many parts of the world (1-3). The
parasite is ovo-viviparous. Its first stage larvae (L1) pass
out with feces through air passages and the
gastrointestinal tract (2-4). L1 is 360-400 µm long and
has a tail with a terminal S-shaped (undulating)
appendage and a subterminal dorsal spine (3,5). After
entering the intermediate host (some species of slugs and
snails), L1 develops to infective L3. Frogs, toads, lizards,
snakes, sparrows, chickens, ducklings and small rodents
may serve as paratenic hosts (2,5,6). Cats are infected
either by ingestion of infected molluscs or by paratenic
hosts (3-5). The prepatent period is 4-6 weeks (1-3, 5).
The duration of patency was recorded as 2-3 months by

Scott (2), 4 months by Urquhart et al. (5), and 4-9
months by Soulsby (3). Some worms may survive in the
lungs for several years without larvae appearing in the
feces (5).

Aelurostrongylus abstrusus often causes infection
without clinical signs. However, in severe infections,
some symptoms such as coughing, sneezing, dyspnea
and polypnea are seen and infection sometimes results
in death (2,3,5). In infected cats, radiographic
abnormalities such as bronchial thickening, bronchial
opacity, focal or generalized alveolar lung disease and
increased vascular and focal parenchymal densities
might be seen (5,7). The literature (2,8-18) on the
treatment of aelurostrongylosis in cats is summarized in
Table 1.
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Table 1.

Summarized information on the treatment of aelurostrongylosis in cats.

Chemicals and dosage

Therapy Results and (Reference)

Fenbendazol: 20 mg/kg daily for 5 days, orally

Larvae disappeared from feces 2-4 weeks after treatment (8)

Fenbendazol: 50 mg/kg daily for 3 days, orally

Parasites were eliminated (9)

Fenbendazol: 55 mg/kg daily for 21 days, orally

Clinical symptoms were resolved by day 6 (10)

Fenbendazol: 50 mg/kg daily 3 successive days, orally

Larvae were absent from feces by day 14 but reappeared from day 18 (11)

Fenbendazol: 20 mg/kg daily for 5 days, twice,
with an interval of 5 days

Feces became free of larvae and symptoms abated (12)

Levamisole: 100 mg orally every other day for
5 treatments

Larvae disappeared from the feces by day 4 and clinical improvement occurred (13)

Levamisole (2.5%): 11 mg/kg daily for 6 days,
subcutaneously

Cats were successfully treated without side effects (14)

1) Levamisole: 30 mg/kg once orally
2) Fenbendazole: 25 mg/kg daily for 5 days

In the levamisole treatment, larvae were absent from fecal smears the next day. But this
drug caused adverse effects. Therefore, treatment was continued with fenbendazole. The cat
was clinically normal after 2 weeks (15)

Tetramisole: 65 or 130 mg/kg daily 5
consecutive days, orally

At 65 mg/kg, fecal larvae counts decreased and clinical signs improved. But relapses
occurred when treatment stopped. No toxicity. At 130 mg/kg, typical organophosphate
toxicity (16)

Tetramisole: 30 or 60 mg/kg every other
day for 10-12 days, orally

At both doses, larvae were absent from the feces 10 days and 30 days after the initial set,
fecal examination was negative for 3 successive days, no toxicity (2)

1) Ivermectin: 0.2 mg/kg, subcutaneously,
2) Levamisole (2%): 30 mg/kg

After unsuccessful treatment with ivermectin, the animal was treated with levamisole (17)

Ivermectin: 1) 0.2 mg/kg, 2) 0.4 mg/kg,
subcutaneously

Initial application did not eliminate infection, a second treatment at a higher rate was
necessary for elimination, drug well tolerated (18)

Case History
A 2-year-old female cat suffering from dyspnea and
incoordination for 18 months was brought to our
department. Its fecal examination revealed nematode
larvae. The larvae had a terminal S-shaped projection and
a subterminal spine. The larvae measured 363-378x15
µm (aver. 370x15 µm, n=10 larvae without fixation)
(Fig. 1), and were identified as Aelurostrongylus
abstrusus according to their characteristics (3,5,19). Two
thoracic radiographs of the cat in different positions were
taken. The evaluation of the radiographs showed slight
bronchial thickening in the lateral position and nodular
opacity on the left lung in the ventro-dorsal position.
The cat was hospitalized, and fecal examination and
larval counting were performed daily between days -2 (2
days before first chemical application) and 64, and
between days 117 and 145. The number of larvae per
gram feces (LPG) was determined by the Baermann
technique (20). The cat was kept at home by its owner
between days 65 and 116 (keeping the cat indoors was
412

Figure 1.

The first stage larva of A. abstrusus in the feces of the cat.
A-General view (scale:100 µm)
B-Caudal end (arrow-a points to the spine and arrow-b to
the S-shaped projection)

recommended). Therefore, LPG values were not
determined between days 65 and 116.
Before the application of moxidectin to the infected
cat, the medicine at a dose of 0.4 mg/kg was given
subcutaneously to 3 healthy stray cats over 1 year old.
These cats were observed for adverse effects for a week
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Table 2.

The LPG (number of larvae per gram feces) values of the cat.

Day

LPG

Day

LPG

Day

LPG

Day

LPG

Day

LPG

Day

LPG

-2

265.3

14

5.24

32

1.25

2M 51

5.32

117

6.91

131

0.97

-1

245.2

15

3.9

33

1.66

52

1.49

118

3.2

133

0.07

1M 0

272.2

16

9.53

36

97.1

53

5.82

119

5.52

135

0.2

3

75

17

2.24

37

38.95

54

37.57

120

6.31

136

0

4

44.46

18

4.09

40

17.56

55

17.59

121

5

88.4

19

8.96

41

25.11

56

15.72

122

6

28.2

20

3.86

42

10.78

57

13.75

7

13.3

21

1.27

43

43.51

58

5.36

8

9.5

22

5.14

44

28.83

60

9

11.2

26

6.31

45

16.02

10

13.16

27

12.63

46

11

9.38

29

46.63

47

12

3.43

31

0.18

50

45.96

10

137

0

1.34

138

0

123

4.31

139

0

124

20.67

140

0

11.6

125

8.87

141

0

61

12.79

126

7.33

142

0

7.57

62

40.77

127

7.69

143

0

1.36

63

3.43

129

10.02

144

0

64

9.83

L 130

7.45

145

0

Abbrev.: The 1st (1M) and 2nd (2M) application days of moxidectin (0.4 mg/kg), and the application day (L) of levamisole (8 mg/kg)

In the present study, the treatment with moxidectin
(0.4 mg/kg) resulted in only a decrease in larval output,
whereas levamisole (8 mg/kg) ceased it within 5 days.
The clinical signs of the cat improved within 5 weeks of
the first application of moxidectin. Neither moxidectin nor
levamisole caused adverse reactions.
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Figure 2.
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Concerning the occurrence of this parasite in Turkey,
only one record is available, in a book written by Oytun in
1961 (21). However, since in this book there is no
literature conforming this record, this paper is the first

As seen in Table 1, the results obtained from the
treatment of aelurostrongylosis with fenbendazole (812), tetramisole (2,16) and ivermectin (17,18) are
controversial. Eventually, 130 mg/kg tetramisole given
orally showed toxicity (16). Another drug, levamisole,
was reported to be effective (13-14) but adverse
reactions were observed in one study (15).

10

Discussion

report on the occurrence of Aelurostrongylus abstrusus in
Turkey.

-2

and no adverse reaction was observed. Then moxidectin
at a dose 0.4 of mg/kg was injected subcutaneously to the
infected cat on day 0. After the application of moxidectin,
LPG values declined sharply until day 12, and they stayed
at very low levels between days 12 and 29 and showed
irregularity after day 29, but never rose even half of the
initial set (Table 2 and Fig. 2). In the cat, dyspnea and
incoordination disappeared within 5 weeks of the
application, but larvae were still present in the feces. The
moxidectin application was repeated on day 51. But the
exact result of this repetition was not obtained because its
owner took the cat away on day 64. After the cat was
brought back, a fecal examination was done on day 117.
The examination showed that the cat was still infected
with the parasite. After the larval output was determined
for 13 days, levamisole at a dose of 8 mg/kg was given
orally to the cat on day 130. Five days after the
application of levamisole, the larvae were absent from the
feces and were not detected throughout the following 10
days (Table 2 and Fig. 2). Neither moxidectin nor
levamisole led to adverse reactions in the cat.

The larval output pattern of the cat.
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